RAYALDEE DIN 02478498
Health Canada record
| Active ingredient(s) | CALCIFEDIOL 30 MCG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A11CC06 CALCIFEDIOL |
| Original market date | |
| Current status date | 09-Feb-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
EirGen Pharma Limited — licence , not currently licensed, last inspection rating C (2025-10-22).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 30106 | 2023-02-09 | New Drug Submission (NDS) | Administrative: Change in Product Ownership |
| 21063 | 2018-07-10 | New Drug Submission (NDS) |
International API supply for CALCIFEDIOL
2 active FDA Drug Master Files.
Request a quote for RAYALDEE